DONATE

Search Results for:

PhD Thesis Defence: Harishankar Balakrishnan

Nanoscale Tomography based in Electrostatic Force Microscopy Harishankar Balakrishnan, Nanoscale bioelectrical characterization group The defence will take place online, if you wish to attend to this defence, you can find … Read more

New molecules allow to switch on and off neuronal circuits using light

Researchers from IBEC, in collaboration with an international team, describe the first molecules capable of regulate glycine receptors with light: Glyght and Azo-NZ1. The new molecules are a promising way to study neuronal circuits, to develop drug-based phototherapies non-invasively, and to understand neurological disorders related with the incorrect functioning of glycine receptors, as hyperekplexia, epilepsy and autism.

Online IBEC Seminar: Mónica Marro

A new molecular dimension: exploiting Raman spectroscopy in Biomedicine Mónica Marro, ICFO, The Institute of Photonic Sciences Raman spectroscopy is a promising optical technique that enables the investigation of the … Read more

Research Assistant at the IMEM-BRT Research Group

Application Deadline: 17/05/2021
Ref: RA-CA

The IMEM-BRT Group is looking for a Research Assistant to collaborate on the project of the development of hybrid nanomembranes for biomedical applications.

IBEC’s Gambit

Taking risks is what science is about. You put all your efforts to pursue one objective and you can either lose or achieve your goal. But losing is not always … Read more

Satisfaction survey

Satisfaction Survey Please take a moment to rate the services provided by IBEC.

Towards a treatment for myotonic dystrophy: the first 3D model with patient cells

IBEC researchers led by Javier Ramón and Juan M. Fernández develop the first three-dimensional model for myotonic dystrophy, a rare disease that currently has no cure. The model combines patient cells and bioengineering techniques and represents a major advance over the use of animals and cell cultures. This new model will help in the design of personalized and more effective treatments, and for drug testing in a much more efficient way.

Postdoctoral position at the Targeted Therapeutics & Nanodevices Research Group


Application Deadline: 18/06/2021
Ref: PD-SM
The Targeted Therapeutics and Nanodevices Research group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral candidate to collaborate in a research project focused on the identification, characterization, and application of “universal” monoclonal antibodies capable of recognizing specific cell-surface receptors in a variety of species, as primary tools to then develop targeted drug delivery applications (nanoparticles and antibody-drug conjugates) for the treatment of neurodegenerative diseases.

The contract will be within the framework of the project “CROSSTARGET: Development of new translational cross-species tools for therapeutic targeting with organ and subcellular precision”, funded by the Ministerio de Ciencia, Innovación y Universidades under its RETOS program.

© 2026 Institute for Bioengineering of Catalonia